<DOC>
	<DOC>NCT01920425</DOC>
	<brief_summary>The objective is to compare the sensitivity and test-retest reliability of Kinesia HomeView to electronic and hand-written diaries for tracking medication state in the home. Demonstrating comparable or superior results will further support use of the Kinesia HomeView system as an outcome measure in clinical drug trials.</brief_summary>
	<brief_title>Kinesia HomeView - Home Diary Comparison</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Clinical diagnosis of Parkinson's disease On a stable antiparkinsonian medication regimen that includes levodopa for at least 4 weeks Experiencing dyskinesia more than 25% of the waking day (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 32) With dyskinesias at least moderately disabling (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 33) Capable of accurately completing diaries Capable of accurately using Kinesia HomeView Significant medical or psychiatric illness Subjects not capable of following the required clinical instructions Serious medical conditions that would compromise safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Parkinson's disease</keyword>
	<keyword>dyskinesia</keyword>
	<keyword>fluctuations</keyword>
	<keyword>tremor</keyword>
	<keyword>bradykinesia</keyword>
	<keyword>levodopa</keyword>
</DOC>